Inanc, NAbacar, KOzturk, MATufan, AKaradeniz, HSari, ICan, GErez, YPehlivan, YDalkiliç, EOcak, TCefle, AYazici, ASenel, AAkar, SEdiboglu, EDKoca, SSSagir, RPYilmaz, SGulcemal, SGündüz, ÖSBasibüyük, CSAlkan, SCesur, TYOnen, F2025-04-102025-04-100003-4967http://hdl.handle.net/20.500.14701/42925EnglishUNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIBMeeting Abstract1468-2060